Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: implications for the neural circuitry of depression

Article Abstract:

Patients who have a return of their depressive symptoms after treatment may have abnormal brain function in the orbitofrontal cortex, the dorsolateral prefrontal cortex, and the thalamus. This was the conclusion of researchers who used PET imaging to measure the metabolic activity in the brains of 18 patients who were successfully treated for depression. They were given a substance that reduces the amount of several neurotransmitters involved in depression.

Author: Charney, Dennis S., Oren, Dan A., Bremner, J. Douglas, Vythilingam, Meena, Ng, Chin K., Vermetten, Eric, Nazeer, Ahsan, Berman, Robert M.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003
Physiological aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Research on major depression: strategies and priorities

Article Abstract:

Priorities for research on depression include identifying susceptibility genes and other risk factors, determining what goes on in the brain during depression, developing new treatments, reducing the suicide rate, decreasing the impact of depression on physical diseases, and educating doctors to provide more effective treatments to patients with depression. Depression is a common, chronic illness that causes much suffering and disability.

Author: Charney, Dennis S., Insel, Thomas R.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis

Article Abstract:

A systematic review and meta-analysis, to quantify the efficacy of antidepressant medications for treatment of combined depression, and substance use disorders is conducted. The result of the study concluded that antidepressant medication, exerts a modest beneficial effect for patients with combined depressive-and substance-use disorders.

Author: Nunes, Edward V., Levin, Frances R.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2004
United States, Health aspects, Care and treatment, Usage, Drug abuse, Alcohols

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Depression, Mental, Depression (Mood disorder), Research
Similar abstracts:
  • Abstracts: The recent case in which boys as young as 10 were accused of rape has disturbing implications for all professionals who work with children
  • Abstracts: Central anticonvulsant effects of magnesium sulfate on N-methyl-D-aspartate-induced seizures. Effect of magnesium sulfate on excitatory amino acid receptors in the rat brain: N-methyl-D-aspartate receptor channel complex
  • Abstracts: Measuring and improving the quality of dying and death. Validation of preferences for life-sustaining treatment: implications for advance care planning
  • Abstracts: Adolescent medicine. The adolescent viewpoint: implications for access and prevention. The National Longitudinal Study on Adolescent Health: preliminary results
  • Abstracts: Non-steroidal anti-inflammatory drugs: indications for use. Understanding the physiological effects of unrelieved pain
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.